↓ Skip to main content
Altmetric
What is this page?
Embed badge
Share
Share on Twitter
Share on Facebook
Share by email
A Phase II Trial Evaluating the Efficacy and Safety of Efavirenz in Metastatic Castration‐Resistant Prostate Cancer
Overview of attention for article published in Oncologist, October 2014
Altmetric Attention Score: 5
About this Attention Score
Good Attention Score compared to outputs of the same age (70th percentile)
Average Attention Score compared to outputs of the same age and source
Mentioned by
twitter
7
X users
facebook
1
Facebook page
Readers on
mendeley
46
Mendeley
Summary
X
Facebook
So far, Altmetric has seen
1
public wall post.
The Oncologist,
26 Jan 2015
REPORT: Phase II Trial Evaluating Efficacy
This page shows the
most recent Facebook posts
that mention this research output.
Click here
to find out how to access more activity.